LEADER 01434nam  2200361Ia 450 
001 9910698843603321
005 20090519150654.0
035   $a(CKB)5470000002397430
035   $a(OCoLC)326879879
035   $a(EXLCZ)995470000002397430
100   $a20090519d2005      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eMedWatch form FDA 3550A, mandatory reporting of adverse reactions related to human cells, tissues, and cellular and tissue-based products (HCT/Ps)
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2005]
215   $ai, 8 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 19, 2009).
300   $a"November 2005".
517   $aGuidance for industry 
606   $aTissue engineering$xSide effects$xReporting$zUnited States
606   $aHuman cell culture$xGovernment policy$zUnited States
615  0$aTissue engineering$xSide effects$xReporting
615  0$aHuman cell culture$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698843603321
996   $aGuidance for industry$93434577
997   $aUNINA